Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

PURPOSE: The efficacy of neoadjuvant chemoradiotherapy (NCRT) plus surgery for locally advanced esophageal squamous cell carcinoma (ESCC) remains controversial. In this trial, we compared the survival and safety of NCRT plus surgery with surgery alone in patients with locally advanced ESCC. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Liu, Hui, Chen, Yuping, Zhu, Chengchu, Fang, Wentao, Yu, Zhentao, Mao, Weimin, Xiang, Jiaqing, Han, Yongtao, Chen, Zhijian, Yang, Haihua, Wang, Jiaming, Pang, Qingsong, Zheng, Xiao, Yang, Huanjun, Li, Tao, Lordick, Florian, D’Journo, Xavier Benoit, Cerfolio, Robert J., Korst, Robert J., Novoa, Nuria M., Swanson, Scott J., Brunelli, Alessandro, Ismail, Mahmoud, Fernando, Hiran C., Zhang, Xu, Li, Qun, Wang, Geng, Chen, Baofu, Mao, Teng, Kong, Min, Guo, Xufeng, Lin, Ting, Liu, Mengzhong, Fu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145832/
https://www.ncbi.nlm.nih.gov/pubmed/30089078
http://dx.doi.org/10.1200/JCO.2018.79.1483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145832/
https://www.ncbi.nlm.nih.gov/pubmed/30089078
http://dx.doi.org/10.1200/JCO.2018.79.1483

Ejemplares similares